Skip to search formSkip to main contentSkip to account menu

UC 781

Known as: UC-781, UC781 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2012
Review
2012
Purpose of reviewIndividuals practicing unprotected receptive anal intercourse are at particularly high risk of HIV infection… 
Review
2012
Review
2012
The CAPRISA 004 study in South Africa has accelerated the development of vaginal and rectal microbicides containing… 
2011
2011
Ethylene vinyl acetate intravaginal rings (IVRs) were prepared by hot-melt compounding and injection moulding. The IVRs contained… 
Review
2010
Review
2010
Purpose of reviewMicrobicide research has been in the forefront of scientific literature in recent months. Results of large-scale… 
Highly Cited
2007
Highly Cited
2007
ABSTRACT The nonnucleoside reverse transcriptase inhibitor UC781 is under development as a potential microbicide to prevent… 
2006
2006
ABSTRACT The nonnucleoside reverse transcriptase inhibitor (NNRTI) UC781 is under development as a microbicide to prevent sexual… 
Highly Cited
2003
Highly Cited
2003
Objective: To determine the efficacy of UC781 in preventing HIV-1 transmission through cervical tissue. Design: Use of human… 
2002
2002
Short exposure of uninfected lymphocytes to UC781, a tight-binding nonnucleoside reverse transcriptase inhibitor (NNRTI), renders… 
Highly Cited
1998
Highly Cited
1998
Background:Thiocarboxanilide UC-781 is a highly potent and selective nonnucleoside reverse transcriptase inhibitor (NNRTI) of HIV… 
1997
1997
A series of compounds related to oxathiin carboxanilide has been identified as nonnucleoside reverse transcriptase inhibitors…